1
James B Fink, Nani P Kadrichu: Aerosolization device. Nektar Therapeutics, Mark A Wilson, October 15, 2013: US08555874 (7 worldwide citation)

An aerosol transfer device for medical aerosol generators includes a body, fluidically coupled to a nebulizer and to a patient interface. An ambient air intake is formed into a lower body. The body is shaped and configured to optimize mixing of ambient air from the ambient air intake and the aerosol ...


2
James B Fink, Nani P Kadrichu: Aerosolization device. Nektar Therapeutics, Mark A Wilson, January 26, 2016: US09242054 (2 worldwide citation)

An aerosol transfer device for medical aerosol generators includes a body, fluidically coupled to a nebulizer and to a patient interface. An ambient air intake is formed into a lower body. The body is shaped and configured to optimize mixing of ambient air from the ambient air intake and the aerosol ...


3
James B Fink, Nani P Kadrichu: Aerosolization device. Nektar Therapeutics, Mark A Wilson, September 29, 2015: US09144650 (1 worldwide citation)

An aerosol transfer device for medical aerosol generators includes a body, fluidically coupled to a nebulizer and to a patient interface. An ambient air intake is formed into a lower body. The body is shaped and configured to optimize mixing of ambient air from the ambient air intake and the aerosol ...


4
James B Fink, Nani P Kadrichu: Aerosolization device. Nektar Therapeutics, Mark A Wilson, June 13, 2017: US09675768

An aerosol transfer device for medical aerosol generators includes a body, fluidically coupled to a nebulizer and to a patient interface. An ambient air intake is formed into a lower body. The body is shaped and configured to optimize mixing of ambient air from the ambient air intake and the aerosol ...


5
James B Fink, Nani P Kadrichu: Aerosolization device. Nektar Therapeutics, May 12, 2011: US20110108025-A1

An aerosol transfer device (10) for medical aerosol generators comprises a body (12), fluidically coupled to a nebulizer (14) and to a patient interface (16). An ambient air intake (20) is formed into a lower body (12C). The body is shaped and configured to optimize mixing of ambient air from the am ...


6
Nani P Kadrichu, James B Fink: Treatment of pulmonary disorders with aerosolized medicaments such as vancomycin. Novartis, Novartis, Corporate Intellectual Property, November 11, 2010: US20100282247-A1

A method of administering an aerosolized anti-infective, such as a glycopeptide, to the respiratory system of a patient. A ratio of an amount of the glycopeptide, such as vancomycin, delivered to the pulmonary system of the patient in a 24 hour period to a minimum inhibitory amount for the target or ...